Publications by authors named "Alka Turuk"
Article Synopsis
- - This study examines how COVID-19 affects cancer patients' risk of death within 30 days of hospitalization, finding that specific types of cancer significantly elevate this risk.
- - Among 51,544 hospitalized COVID-19 patients, 976 had cancer; solid cancers had a particularly high mortality rate of 25%.
- - The research emphasizes the importance of tailored monitoring and treatment for COVID-19 patients with cancer, especially during the first 10 days of hospitalization, as this is when the risk of severe outcomes is greatest.
Article Synopsis
- A study was conducted in India to investigate sudden unexplained deaths among healthy young adults (ages 18-45) possibly linked to COVID-19 infection or vaccination from October 2021 to March 2023.
- The research analyzed data from 729 cases and 2,916 matching controls, assessing factors like COVID-19 vaccination status, family history, substance use, and physical activity.
- Results indicated that receiving at least one COVID-19 vaccine dose reduced the likelihood of sudden death, while factors such as past hospitalization for COVID-19, family history of sudden deaths, binge drinking, and intense physical activity increased the risk.
Article Synopsis
- - The analysis aimed to determine the prevalence of tuberculosis (TB) infection in India, revealing that approximately 22.6% of the population over 15 years old is infected with TB.
- - Data from the National TB prevalence survey indicated that factors such as being over 30 years old, male gender, urban residency, and having a previous TB history are significantly associated with higher TB infection rates.
- - The study highlights the need for targeted interventions and monitoring to effectively address and reduce the high burden of TB in India.
Introduction: The effects of COVID-19 infection persist beyond the active phase. Comprehensive description and analysis of the post COVID sequelae in various population groups are critical to minimise the long-term morbidity and mortality associated with COVID-19. This analysis was conducted with an objective to estimate the frequency of post COVID sequelae and subsequently, design a framework for holistic management of post COVID morbidities.
View Article and Find Full Text PDFBackground & Objectives: The post-acute effects of COVID-19 are continually being updated. This investigation was conducted to evaluate the determinants of post discharge mortality in hospitalized COVID-19 patients, especially 18-45 yr of age.
Methods: A series of three nested case-control analyses was conducted on follow up data collected in the National Clinical Registry for COVID-19 between September 2020 and February 2023 from 31 hospitals.
Background: Patients admitted to intensive care units (ICUs) with severe coronavirus disease (COVID-19) are associated with high mortality. The present retrospective, multicenter study describes the predictors and outcomes of COVID-19 patients requiring ICU admission from COVID-19 Registry of Indian Council of Medical Research (ICMR), India.
Materials And Methods: Prospectively collected data from participating institutions were entered into the electronic National Clinical Registry of COVID-19.
Objective: To evaluate the factors associated with mortality of a multicentric cohort of hospitalized COVID-19 patients, 0-18 y old, from 42 centers across India.
Methods: The National Clinical Registry for COVID-19 (NCRC) is an on-going prospective data collection platform enrolling COVID-19 patients diagnosed by real-time PCR or rapid antigen test. The data are collected in prestructured e-capture forms.
Background & Objectives: Data from the National Clinical Registry for COVID-19 (NCRC) were analyzed with an aim to describe the clinical characteristics, course and outcomes of patients hospitalized with COVID-19 in the third wave of the pandemic and compare them with patients admitted earlier.
Methods: The NCRC, launched in September 2020, is a multicentre observational initiative, which provided the platform for the current investigation. Demographic, clinical, treatment and outcome data of hospitalized COVID-19 patients were captured in an electronic data portal from 38 hospitals across India.
Background: Earlier serosurveys in India revealed seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) of 0.73% in May-June 2020 and 7.1% in August-September 2020.
View Article and Find Full Text PDFBackground: The first national severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serosurvey in India, done in May-June, 2020, among adults aged 18 years or older from 21 states, found a SARS-CoV-2 IgG antibody seroprevalence of 0·73% (95% CI 0·34-1·13). We aimed to assess the more recent nationwide seroprevalence in the general population in India.
Methods: We did a second household serosurvey among individuals aged 10 years or older in the same 700 villages or wards within 70 districts in India that were included in the first serosurvey.
Article Synopsis
- * A total of 28,000 individuals were tested for IgG antibodies, revealing a population-weighted seroprevalence of 0.73%, equating to approximately 6.47 million adult infections by early May.
- * Factors such as being male, residing in urban slums, and having high-risk occupations were linked to higher seropositivity, with an infection case ratio ranging from 81.6 to 130.1 and